The Future of CML Treatment

Chapter 7

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses what he feels are the most important considerations in the future of CML treatment and research.

Chapter 1

Progress in the Landscape of CML Treatment

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the progress in treatment strategies for patients with chronic myeloid leukemia over the last 16 years.

Chapter 2

Sequencing Treatment for Patients with CML

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the available tyrosine kinase inhibitors for the treatment of CML and his strategy for sequencing treatment in patients with chronic myeloid leukemia.

Chapter 3

Monitoring Treatment Response in Patients With CML

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, highlights the importance of monitoring patients with chronic myeloid leukemia and gives specific guidance on best practices.

Chapter 4

Switching Therapies in CML Treatment

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the decisions related to switching therapy for patients with chronic myeloid leukemia.

Chapter 5

Known Factors in TKI Resistance

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the facts that can cause tyrosine kinase resistance and how they should be addressed in the clinical setting.

Chapter 6

Allogeneic Stem Cell Transplant in CML

In this video Hagop M. Kantarjian, MD, a professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, outlines the appropriate scenarios for the consideration of allogeneic stem cell transplant in patients with chronic myeloid leukemia.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs